Thursday 29 September 2016

Oral Posters - Functional and Miscellaneous

Chairs: Dimitri Christoforidis (Switzerland), Ole Helmer Sjo (Norway)

• OP19: Fecal incontinence treated by sacral neuromodulation: world’s largest single center study - P.T.J. Janssen (The Netherlands)
• OP20: Predictive factors of success after magnetic anal sphincter augmentation for fecal incontinence - Mia Kim (Germany)
• OP21: An investigation into the efficacy of transcutaneous electric nerve stimulation on acupoints (Acu-TENS) for the treatment of faecal incontinence - Tony Mak (Hong Kong)
• OP22: Chronic pain after rectal cancer treatment development and validation of a scoring system for post-surgical chronic pain - Alexander Mortensen (Denmark)
• OP23: Intra-operative adverse events during laparoscopic ventral mesh rectopexy - Mostafa Shalaby (Italy)
• OP24: Adhesive small bowel obstruction: Trends in incidence, management and outcomes over 15 years - Mohamed Abdelhalim (UK)
• OP25: No increased risk of complications after a first episode of uncomplicated diverticulitis - Kalle Andreasson (Sweden)
• OP26: Global variations in the outcome of emergency abdominal surgery: multicentre, international, prospective, cohort study - GlobalSurg Collaborative (UK)
• OP27: Angiotensin-converting enzyme inhibitors (ACEi), but not angiotensin receptor blockers (ARBs) are associated with ischaemic colitis - AS Ewing (UK)
• OP28: Transversus abdominis plane (TAP) block in laparoscopic colorectal surgery: a meta-analysis - Elisabeth Hain (France)
• OP29: Considerations for Hartmann's reversal - a multicenter study from the Israeli Hartmann's reversal group - Oded Zmora (Israel)
• OP30: Laparoscopic lavage or colonic resection for acute perforated sigmoid diverticulitis: a systematic review and meta-analysis - Faisal Shaikh (Ireland)
• OP31: Prevalence and 1-year mortality of acute kidney injury after colorectal cancer surgery: a population-based study - Charlotte Slagelse (Denmark)
• OP32: Compression versus hand-sewn and stapled anastomosis in colorectal surgery: a systematic review and meta-analysis of randomised controlled trials - Alistair Slesser (UK)
• OP33: Surveillance of duodenal polyposis in familial adenomatous polyposis: should the Spigelman score be modified? - Isabelle Sourrouille (France)

Oral Posters - Neoplasia

Chairs: Conor Shields (Ireland), Anna Lepistö (Finland)

• OP34: A prospective cohort of metachronous cancers in a lynch population - Jeremie Lefevre (France)
• OP35: Management of suspicious pelvic sidewall nodes in patients with rectal cancer - Victoria Banwell (UK)
• OP36: Standardised laparoscopic colon surgery can achieve oncological outcomes comparable to open complete mesocolic excision with reduced morbidity: a 601 case multicentre experience - Nick J Battersby (UK)
• OP37: Prevalence and characteristics of unexpected rectal cancer in bening appearing large non-pedunculated rectal polyps - Maxime Bronzwaer (The Netherlands)
• OP38: Going 'straight to test': telephone assessment clinics can provide a more efficient way of dealing with two week wait colorectal cancer referrals - Danielle Browning (UK)
• OP39: The depth of the tumor infiltration into the mesocolic fat is a risk factor for bad oncologic outcome after pT3 colon cancer resection - Carlos Cerdán (Spain)
• OP40: Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer: The experience of two European tertiary colorectal centres - Quentin Denost (France)
• OP41: Oncological safety and evolution of intersphincteric resection over 25 years - Quentin Denost (France)
• OP42: The effect of sphincter-preservation and radiation on long-term quality of life in low rectal cancer. A national retrospective study - Katrine Emmertsen (Denmark)
• OP43: Greater regression of extramural venous invasion is observed on post treatment MRI at 12- weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy - Jessica Evans (UK)
• OP44: Oncologic results after conventional and extraelevator abdominoperineal rectal excision. Analysis of a consecutive institutional series - Matteo Frasson (Spain)
• OP45: How does the robotic approach manage pitfalls in rectal surgery? A European prospective, multicenter evaluation - Marcos Gómez Ruiz (Spain)
• OP46: Adenomatous-like lesions at restaging endoscopy after chemoradiotherapy for rectal cancer: candidates for a Watch-and-Wait policy? - Britt Hupkens (The Netherlands)
• OP47: A nationwide MRI study of pelvic insufficiency fractures after preoperative radiotherapy for rectal cancer - Jesper Beck Jørgensen (Denmark)
• OP48: Oncologic outcomes of metallic stent insertion before surgery versus immediate surgery for obstructing left-sided colorectal cancer: a multicenter comparative study using propensity score analysis - Sung Il Kang (Republic of Korea)

07:30 - 10:15

ESCP Guidelines Update

Chairs: Carolynne Vaizey (UK), Yves Panis (France)

• Intestinal failure guidelines update - Carolynne Vaizey (UK)
• Proposed haemorrhoidectomy scoring system - Stephanie Breukink (The Netherlands)
• ECCO/ESCP surgical guidelines on Crohn’s disease - Andre D'Hoore (Belgium)
• ESCP’s future guidelines priorities: interactive debate

08:45 - 10:15

New Trials Forum

Presentation and review of new trials in the ESCP

Chair: Dion Morton (UK)

Expert panel: André D'Hoore (Belgium), Peter Christensen (Denmark), Carolynne Vaizey (UK), Oded Zmora (Israel)

New trials presentations: four proposals reviewed by the expert panel

• T01: STAR-TREC: can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo)Radiotherapy versus Total mesorectal excision for early Rectal Cancer? - Simon Bach (UK)
• T02: SupPoRtive Exercise Programmes for Accelerating REcovery after major ABdominal Cancer surgery (PREPARE-ABC) - James Hernon (UK)
• T03: Preparation with mechanical bowel cleansing or/and oral antibiotics or nothing for elective colorectal surgery Two-Two-Arm Multicentre Randomised Controlled Studies (MECCLAND –C and –R Trials) - Evaghelos Xynos (Greece)
• T04: Neoadjuvant chemotherapy in locally advanced colon cancer- ELECLA trial - Jorge Arredondo (Spain)

Guidelines synthesis: guideline synopsis on rectal preserving treatment options - Pieter Tanis (Netherlands)

• Announcing the ESCP cohort study for 2017 - Alaa El-Hussuna (Denmark)
• Trial posters T05-T13 will be available nearby during this session

Keynote Lecture: Cytoreductive Surgery and HIPEC in Colorectal Cancer

Chair: Selman Sokmen (Turkey)

Speaker: Olivier Glehen (France)

10:45 - 12:45

ESCP President's Address

Stefan Post - ESCP President

11:55 - 13:05

The Six Best Free Papers

Chairs: Stefan Post (Germany), Anna Martling (Sweden)

• B1: Right colectomy for cancer. Results of a trans-continental prospective study including 2536 patients - ESCP 2015 Pan-European Audit Collaborative Group (UK)
• B2: Formal surgical competence level and survival after coloncancer surgery - Mile Bergvall (Sweden)
• B3: Results of a prospective randomised control 6 vs 12 trial: is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy? - Jessica Evans (UK)
• B4: Pelvic local recurrence: surgical challenge with changing preconditions - Henrik Iversen (Sweden)
• B5: Haemorrhoidal artery ligation versus rubber band ligation: results and economic analysis of a multicentre, randomised controlled trial - Jim Tiernan (UK)
• B6: The presence of Irritable Bowel Syndrome predicts the severity of fecal incontinence after acute obstetric sphincter repair rather than the presence of a sphincter defect - Alexander Engel (Australia)

14:15 - 15:15

ESCP/ECCO Symposium: What's New in IBD?

Chair: Tom Øresland (Norway), Steven Wexner (USA)

• TAMIS pouch surgery: a new paradigm? - Janindra Warusavitarne (UK)
• Irritable pouch syndrome, cuffitis and pouchitis: what to do - Ailsa Hart (UK)
• Surgical causes and (TAMIS) solutions for pouch dysfunction - Willem Bemelman (The Netherlands)

An ESCP session developed in collaboration with S-ECCO

ESCP/EAES Symposium: Minimally Invasive Procedures for Rectal Prolapse

Chairs: Eduardo Targarona (Spain), Roberto Bergamaschi (USA)

• Overview on functional outcome and recurrence - Alexander Engel (Australia)
• Laparoscopic/robotic ventral approach - André D'Hoore (Belgium)
• Posterior approach - Eduardo Targarona (Spain)

A jointly organised EAES/ESCP session

International Travelling Fellow Free Papers

Chairs: Emmanuel Tiret (France), Claudio Wainstein (Chile)

• ASCRS Visiting Fellow: Simvastatin enhances radiation sensitivity of colorectal cancer cells by targeting the EGFR-RAS-ERK axis - Matt Kalady (USA)
• JSCP Visiting Fellow: Oncological outcomes of laparoscopic total mesorectal excision with extended lateral pelvic lymph node dissection for advanced lower rectal cancer after preoperative chemoradiotherapy - Takashi Akiyoshi (Japan)
• KSCP Visiting Fellow: Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach - Hye Jin Kim (Korea)

Keynote Lecture: Surgical Management of Intestinal Failure

Chair: Yves Panis (France)

Speaker: Iain Anderson (UK)

Supported by a grant from the British Journal of Surgery

Free Papers (Neoplasia)

Chairs: Dursun Bugra (Turkey), Gunnar Baatrup (Denmark)

• F25: Who is the ideal patient to be safely discharged after three days within an enhanced recovery surgery (ERAS) protocol - Jimmy Ng (UK)
• F26: Quality of life in the randomized trial EASY - early closure of a temporary ileostomy after rectal resection for cancer - Jennifer Park (Sweden)
• F27: Does time from primary colorectal cancer resection to recurrence affect survival after cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases? - Abhilasha Patel (UK)
• F28: Health related quality of life three years after abdominoperineal excision for rectal Cancer - Anna Ledebo (Sweden)
• F29: Laparoscopic modified mesocolic excision with central vascular ligation in right-sided colon cancer shows better oncologic outcomes compared with the open approach - Jung Kyong Shin (Republic of Korea)
• F30: Chemoradiation followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: long term results of the CARTS study - R.C.H. Stijns (The Netherlands)

Free Papers (Randomised Clinical Trials)

Chair: Oded Zmora (Israel)

Co-chairs: Thomas Pinkney (UK), Søren Laurberg (Denmark)

• F31: The ACCURE-UK trial: the effect of appendectomy on the clinical course of ulcerative colitis - a randomised feasibility trial - Dmitri Nepogodiev (UK)
• F32: Transanal versus abdominal low rectal dissection for rectal cancer: long term results of the Bordeaux’ randomized trial - Quentin Denost (France)
• F33: Is there a difference in surgical morbidity and mortality when surgery is delayed to 12-weeks versus 6-weeks post neoadjuvant chemoradiotherapy for locally advanced rectal cancer? - Jessica Evans (UK)
• F34: Early closure of a temporary ileostomy in patients with rectal cancer: a multicenter randomized controlled trial - Jennifer Park (Sweden)
• F35: Complete Mesocolic Excision vs. standard right hemicolectomy Trial (COMET) - Nathan Curtis (UK)
• F36: Randomised multicenter trial on the usefulness of intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients who undergo laparoscopic rectal resection or left colectomy - Maggiore Riccardo (Italy)

Keynote Lecture: Multidisciplinary Management of Perianal Crohn's Disease

Chair: Zoran Krivokapic (Serbia)

Speaker: André D'Hoore (Belgium)

Supported by Colorectal Disease